APA (7th ed.) Citation

Mingione, A., Corona, A., Monzani, C., Zollo, A., Cirocco, C., Zaccone, T., . . . Martinelli-Boneschi, F. (2026). Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis. International Journal of Molecular Sciences, 27(3), 1441. https://doi.org/10.3390/ijms27031441

Chicago Style (17th ed.) Citation

Mingione, Alessandra, et al. "Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis." International Journal of Molecular Sciences 27, no. 3 (2026): 1441. https://doi.org/10.3390/ijms27031441.

MLA (9th ed.) Citation

Mingione, Alessandra, et al. "Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis." International Journal of Molecular Sciences, vol. 27, no. 3, 2026, p. 1441, https://doi.org/10.3390/ijms27031441.